Ubs Asset Management Americas Inc G1 Therapeutics, Inc. Transaction History

Ubs Asset Management Americas Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.57 - $8.16 $70,161 - $222,768	27,300 Added 221.95%	39,600 $106,000
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $63,837 - $166,050	12,300 New	12,300 $66,000
Q2 2022 Aug 12, 2022	SELL	$4.04 - $8.51 $165,684 - $349,003	-41,011 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.57 - $26.32 $56,733 - $76,301	2,899 Added 7.61%	41,011 $899,000
Q1 2021 May 14, 2021	BUY	$17.58 - $32.59 $74,222 - $137,594	4,222 Added 12.46%	38,112 $916,000
Q4 2020 Mar 01, 2021	BUY	$10.99 - $20.4 $95,030 - $176,398	8,647 Added 34.26%	33,890 $609,000
Q3 2020 Nov 13, 2020	BUY	$11.55 - $23.75 $15,915 - $32,727	1,378 Added 5.77%	25,243 $291,000
Q2 2020 Aug 14, 2020	SELL	$9.57 - $24.37 $1.79 Million - $4.56 Million	-187,248 Reduced 88.7%	23,865 $578,000
Q1 2020 May 15, 2020	SELL	$9.07 - $26.32 $372,985 - $1.08 Million	-41,123 Reduced 16.3%	211,113 $2.33 Million
Q4 2019 Feb 14, 2020	BUY	$20.54 - $31.0 $161,033 - $243,040	7,840 Added 3.21%	252,236 $6.67 Million
Q3 2019 Nov 14, 2019	SELL	$22.78 - $40.58 $111,303 - $198,273	-4,886 Reduced 1.96%	244,396 $5.57 Million
Q2 2019 Aug 15, 2019	BUY	$16.03 - $31.1 $1.82 Million - $3.52 Million	113,294 Added 83.31%	249,282 $0
Q1 2019 May 14, 2019	BUY	$14.4 - $21.45 $10,238 - $15,250	711 Added 0.53%	135,988 $0
Q4 2018 Feb 13, 2019	SELL	$16.51 - $51.33 $241,689 - $751,419	-14,639 Reduced 9.76%	135,277 $2.59 Million
Q3 2018 Nov 14, 2018	BUY	$43.15 - $67.97 $6.47 Million - $10.2 Million	149,916 New	149,916 $0

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.